首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   231篇
  免费   15篇
  国内免费   2篇
  248篇
  2024年   1篇
  2023年   2篇
  2022年   5篇
  2021年   7篇
  2020年   4篇
  2019年   1篇
  2018年   9篇
  2017年   1篇
  2016年   9篇
  2015年   11篇
  2014年   9篇
  2013年   14篇
  2012年   14篇
  2011年   20篇
  2010年   9篇
  2009年   17篇
  2008年   20篇
  2007年   10篇
  2006年   6篇
  2005年   14篇
  2004年   8篇
  2003年   13篇
  2002年   5篇
  2001年   2篇
  2000年   1篇
  1999年   7篇
  1998年   2篇
  1997年   3篇
  1996年   1篇
  1995年   2篇
  1993年   1篇
  1990年   2篇
  1989年   2篇
  1988年   2篇
  1987年   4篇
  1985年   2篇
  1982年   1篇
  1979年   1篇
  1976年   1篇
  1974年   1篇
  1973年   1篇
  1972年   1篇
  1967年   1篇
  1958年   1篇
排序方式: 共有248条查询结果,搜索用时 15 毫秒
71.
From the aerial parts of Barleria prionitis, one new phenylethanoid glycoside, barlerinoside (1) along with six known iridoid glycosides, shanzhiside methyl ester (2), 6-O-trans-p-coumaroyl-8-O-acetylshanzhiside methyl ester (3), barlerin (4), acetylbarlerin (5), 7-methoxydiderroside (6), and lupulinoside (7) were isolated. Structures of these compounds were elucidated with the aid of extensive NMR spectral studies and chemical reactions. Compound 1 was significantly active in glutathione S-transferase (GST) inhibition assay with an IC50 value of 12.4 μM but weakly active in acetylcholinesterase (AChE) inhibition assay. Compounds 27 also exhibited different levels of GST, AChE inhibitory and free radical scavenging activities.  相似文献   
72.
Cell motility, adhesion and actin cytoskeletal rearrangements occur upon integrin-engagement to the extracellular matrix and activation of the small family of Rho GTPases, RhoA, Rac1 and Cdc42. The activity of the GTPases is regulated through associations with guanine nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs) and guanine dissociation inhibitors (GDIs). Recent studies have demonstrated a critical role for actin-binding proteins, such as ezrin, radixin and moesin (ERM), in modulating the activity of small GTPases through their direct associations with GEFs, GAPs and GDI''s. Dematin, an actin binding and bundling phospho-protein was first identified and characterized from the erythrocyte membrane, and has recently been implicated in regulating cell motility, adhesion and morphology by suppressing RhoA activation in mouse embryonic fibroblasts. Although the precise mechanism of RhoA suppression by dematin is unclear, several plausible and hypothetical models can be invoked. Dematin may bind and inhibit GEF activity, form an inactive complex with GDI-RhoA-GDP, or enhance GAP function. Dematin is the first actin-binding protein identified from the erythrocyte membrane that participates in GTPase signaling, and its broad expression suggests a conserved function in multiple tissues.Key words: dematin, RhoA, actin, GTPase, signalingCell adhesion and motility are mediated through activation of integrin receptors and the family of small Rho GTPases.1 Engagement of integrin receptors to the extracellular matrix leads to the activation of multiple kinase pathways (i.e., FAK, Src), inducing the assembly of the focal adhesion complex and actin/myosin contraction. Furthermore, activation of the receptor tyrosine kinases (i.e., insulin receptor) or G-protein coupled receptors (i.e., LPA receptor), leads to downstream signaling events that also trigger multiple kinase pathways that regulate the protrusive and contractile actin/myosin dynamics. These adhesion-dependent or receptor-driven signaling cascades ultimately result in the activation of the small family of Rho GTPases: Cdc42, Rac1 and RhoA, key regulators of actin cytoskeleton assembly. The activation of these GTPases induces lamellipodia (Rac1), filopodia (Cdc42), actin stress fiber formation (RhoA) and focal adhesion complex formation (Rac1 and RhoA). Nascent focal adhesion complex formation within the lamellipodia is a result of Rac1 activation;2 however, mature focal adhesions and actin cytoskeletal rearrangements are a direct consequence of RhoA activation.3The regulation of RhoA activity occurs through its interactions with guanine nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs) and guanine dissociation inhibitors (GDIs) (reviewed in refs. 46). The regulatory intricacies that govern RhoA association with GEFs, GAPs and GDIs remain poorly understood. However, it is now well accepted that actin-binding proteins participate and play a significant role in regulating the functional activity of RhoA GTPase through their direct association with RhoGEFs, GDI''s and RhoGAPs (7

Table 1

List of actin-binding proteins that are known to directly bind to GEFs, GAPs or GDIs and regulate RhoA activation
GEF/GAP/GDIActin binding proteinRef.
GEFsdblRadixin31
TrioTARA32
LfcSpinophilin33
LfcNeurobin33
GAPsCdGAPActopaxin19
Rgd1Vrp120
GDIsRhoGDIEzrin/Radixin/Moesin21
RhoGDIMerlin34
Open in a separate windowDematin, previously known as erythrocyte membrane protein band 4.9, is a member of the villin family of headpiece-containing actin-binding proteins. It contains a c-terminal actin-binding domain, and an N-terminal “core-domain” of unknown function.8,9 Dematin was first isolated and characterized from the mature erythrocyte membrane,10,11 where it functions to maintain erythrocyte shape and membrane structural integrity via a novel linkage at the actin-spectrin junctional complex through glucose transporter-1 (GLUT1) in a species specific manner.12 Despite its wide-spread expression, relatively little is known about the biological function of this actin-binding protein in non-erythroid cells. Previous studies have shown that the human dematin gene (EPB4.9) maps to 8p21.1,9 a chromosomal region that is frequently deleted in prostate cancers. Interestingly, it was demonstrated that a sub-set of metastatic prostate tumors show a loss of heterozygosity of the dematin gene. Furthermore, it was demonstrated that in PC-3 cells, a prostate cancer cell line, the overexpression of the dematin gene was able to revert the oncogenic morphology (cell rounding) to a normal prostate epithelial morphology (microvillar and cytoplasmic extensions), thus suggesting a possible role for dematin in modulating these cellular processes.13 To determine the in vivo function of dematin, a dematin headpiece-null mouse (HPKO) model was generated in our laboratory, lacking the c-terminal actin binding headpiece domain. Consequently, the HPKO model expresses a truncated variant of dematin containing the N-terminal “core-domain.” Hematological analysis of the HPKO erythrocytes revealed evidence of membrane fragility, spherocytosis and mild hemolytic anemia.14 Since the loss of the dematin actin-binding headpiece resulted in morphological defects in the erythrocyte, we extended these studies to investigate if these defects would manifest in non-erythroid cells. Isolated mouse embryonic fibroblasts from HPKO mice display abnormal cell morphology, motility and adhesion, presumably resulting from RhoA hyperactivation and subsequent phosphorylation of downstream signaling molecules, such as focal adhesion kinase (FAK) and myosin light chain (MLC).7 These data suggest that dematin acts upstream of RhoA perhaps by associating with one of the known regulators of RhoA activation: GEFs, GAPs and GDIs (Fig. 1).Open in a separate windowFigure 1Hypothetical models of dematin mediated regulation of RhoA signaling. (A) Dematin has been shown to bind the DH domain of RasGRF2, but does not modulate Rac1 or Ras activation through RasGRF2. In several yeast-2-hybrid RasGRF2 clones, an insert from the GEFD2 domain of the RhoA GEF, Trio, was identified. It is possible that dematin may bind to and inhibits the RhoA GEF activity on Trio. (B) Dematin may complex with GDI and inactive RhoA-GDP, by tethering GDI to the actin cytoskeleton. The release of dematin from the cytoskeleton results in RhoA-GDP release and activation. (C) Dematin may also act to spatially localize RhoGAP to enhance the activity on RhoA-GTP, which in turn results in RhoA suppression.Previous evidence has shown that dematin binds to calcium activated Ras-guanine nucleotide-releasing factor 2 (RasGRF2).15 RasGRF2 is a bifunctional guanine nucleotide exchange factor (GEF) that can modulate the activation of Ras through its Cdc25 domain and Rac1 through its DH-PH domains (Dbl and Plekstrin homology domains).16 Although dematin binds to the DH domain of RasGRF2, dematin was unable to modulate the activation of Rac1 or Ras. Moreover, the yeast-2 hybrid results revealed that several of the isolated RasGRF2 clones contained an insert from the GEFD2 domain of Trio, a RhoA GEF.17 It is therefore plausible, that in vivo, dematin associates with Trio, and inhibits RhoA activation, similar to TRIPalpha, the first known inhibitor of a RhoA GEF, which specifically blocks the Trio GEFD2-exchange activity of RhoA.18 The significance of the postulated in vivo dematin interactions with Ras-GRF2 and TrioRhoGEF has not been established, but taken together; this model may provide a mechanistic link between dematin and RhoA (Fig. 1).RhoGAPs catalyze the hydrolysis of the active GTP-bound state of RhoA to the inactive GDP-bound form through intrinsic GTPase activity. Although there is no indication that dematin binds to a RhoGAP, it is possible that dematin behaves similarly to actopaxin19 and VRP1,20 actin-binding proteins that provide spatial and temporal regulation of RhoGAP function, and consequently RhoA inhibition. In addition to the regulation of RhoA through GEFs and GAPs, the actin-binding proteins, ezrin, radixin and moesin (ERMs) are known to sequester the guanine dissociation inhibitor, GDI, from RhoGDP.21 The tethering of GDI to the actin cytoskeleton reduces GDI activity, resulting in an increase in RhoA activation. Furthermore, recent studies have shown that PKA phosphorylation of GDI results in an increase in the association between GDI and RhoA-GDP, thus resulting in a decrease in RhoA activity.22 Interestingly, PKA phosphorylates and inhibits dematin''s actin-bundling activity by inducing a conformational change in the dematin actin-binding headpiece domain.10,23 It is possible that in the absence of PKA, dematin robustly interacts with GDI resulting in a stronger and tighter linkage to the actin cytoskeleton; thus in turn resulting in an increase in RhoA activation. Phosphorylation of dematin by PKA may result in the release of GDI from dematin and the actin cytoskeleton and causing subsequent suppression of RhoA activity. It is also possible that dematin retains inactive Rho-GDP in the cytosol, through an association with RhoGDI and the actin cytoskeleton. RhoA activation would occur when the dematin-RhoGDI-RhoA-GDP complex disassociates from the cytoskeleton via intracellular signaling events (Fig. 1).In addition to the aforementioned mechanisms of RhoA regulation through GEFs, GAPs and GDIs, it is also possible that dematin participates in the signaling cascade several steps upstream of RhoA activation. Dematin''s interaction with GLUT1,12 and with the scaffolding protein 14-3-3ζ may provide alternative models to investigate the mechanism of dematin-mediated suppression of RhoA. Since dematin interacts with GLUT1, it is possible that dematin mediates GLUT1 trafficking to the plasma membrane. In the absence of dematin, GLUT1 trafficking may be altered, thus resulting in abnormal glucose uptake. Metabolic defects have significant effects on intracellular signaling, which manifest itself in a variety of phenotypes, such as altered cell morphology, motility and adhesion.25 Proteomic analysis, as well as seven consensus 14-3-3 binding motifs, suggests that dematin may interact in vivo with the scaffolding protein, 14-3-3ζ.24 Recent evidence has shown that PI3-Kinase/Akt activation induces the association of an ankyrin repeat domain-containing protein, KANK, with 14-3-3ζ, which in turn results in RhoA activation.26 The mechanism by which KANK negatively regulates 14-3-3ζ-activation of RhoA is unknown. However, it has been reported that the RhoGEF, AKAP-Lbc, is inhibited by anchoring PKA to 14-3-3ζ.27 It is thus possible that dematin exists in a similar complex to suppress RhoA activation.The unexpected finding that dematin functions as a suppressor of RhoA activity has its significance as being the first protein isolated from the erythrocyte that has been functionally linked to a small GTPase and regulates its activity. There is a significant amount of RhoA in the human erythrocytes,28 and it is possible that other cytoskeletal components of the erythrocyte membrane are also able to modulate small Rho-GTPases in vivo. Recent evidence has implicated the small GTPase, Rac1 and Rac2 in modulating the deformability of the erythrocyte membrane29 and Rac GTPases together with mDia2 regulate enucleation in mammalian erythroblasts.30 Although the precise mechanism of these processes is not yet clear, it raises the possibility that the erythrocyte membrane yet again serves as a paradigm for elucidating fundamental biochemical processes beyond the field of red cell biology. Future studies on the dematin-RhoA signaling pathway will be directed toward elucidating the mechanism by which dematin is able to suppress RhoA activation in relevant cell types.  相似文献   
73.
From the aerial parts of Buxus hyrcana, three triterpenoidal alkaloids, 17-oxo-3-benzoylbuxadine (1), buxhyrcamine (2), and 31-demethylcyclobuxoviridine (3), along with 16 known compounds, cyclobuxoviridine (4), Nb-dimethylcyclobuxoviricine (5), E-buxenone (6), Z-buxenone (7), moenjodaramine (8), homomoenjodarmine (9), buxamine A (10), buxamine B (11), 31-hydroxybuxamine B (12), N20-formylbuxaminol E (13), papillozine C (14), buxmicrophylline F (15), buxrugulosamine (16), cyclobuxophylline O (17), spirofornabuxine (18) and arbora-1,9(11)-dien-3-one (19) were isolated. Their structures were elucidated by using NMR spectroscopic methods. All of the compounds exhibited moderate to weak acetylcholinesterase, butyrylcholinesterase and glutathione S-transferase inhibitory activities. Compounds 119 also exhibited modest anti-fungal activities against Candida albicans. Compounds 1, 2, 8, 9 and 18 also exhibited weak anti-leishmanial activity.  相似文献   
74.
Iron overload has been shown to enhance chemically mediated cutaneous tumor promotion in animals. However, the majority of these animal studies have used high concentrations of iron before initiating tumor development. The current study was designed to evaluate the effect of small doses of iron on the promotion stage of chemically mediated cutaneous carcinogenesis. We found an increased tumor response in mice initiated with dimethylbenz(a)anthracene (DMBA) when iron at the dose levels of 0.5, 1.0, and 1.5mg/mouse was injected (intramuscularly) once a week into mice at the promotion stage of skin carcinogenesis, employing 12-O-tetradecanoyl phorbol-13-acetate (TPA)/benzoyl peroxide (BPO) as tumor promoter. The appearance of first papilloma and the number of tumors/mouse were recorded weekly. When compared to the control (non-iron-treated) group, the iron-treated groups showed an augmented incidence of tumors and number of tumors/mouse. In iron-treated mice, tumors appeared earlier than in the control group. TPA/BPO treatment resulted in a significant decrease in the activities of antioxidant enzymes and depletion in the level of epidermal reduced glutathione (GSH). TPA treatment in non-iron-treated mice resulted in approximately 20-40% decrease in GSH level and in the activities of antioxidant enzymes, whereas 1.5-mg iron treatment along with TPA treatment resulted in about approximately 30-70% decrease in GSH level and in the activities of antioxidant enzymes. Similarly, treatment of iron along with BPO treatment resulted in a dose-dependent higher depletion of GSH and the antioxidant enzymes as compared to non-iron-treated animals treated with BPO. Further, TPA/BPO-mediated induction in ornithine decarboxylase activity and [3H]thymidine incorporation in cutaneous DNA was approx two- to threefold higher in mice treated with iron as compared to non-iron-treated mice. Cutaneous lipid peroxidation and iron levels were also higher in mice treated with iron as compared to non-iron-treated mice. These data suggest that progressive iron overload can enhance the tumor promotion ability of TPA/BPO in DMBA-initiated murine skin.  相似文献   
75.
Falcipain-2 (FP-2) is a dual-function protease that cleaves hemoglobin at the early trophozoite stage and erythrocyte membrane ankyrin and protein 4.1 at the late stages of parasite development. FP-2-mediated cleavage of ankyrin and protein 4.1 is postulated to cause membrane instability facilitating parasite release in vivo. To test this hypothesis, here we have determined the precise peptide sequence at the hydrolysis site of ankyrin to develop specific inhibitor(s) of FP-2. Mass spectrometric analysis of the hydrolysis products showed that FP-2-mediated cleavage of ankyrin occurred immediately after arginine 1,210. A 10-mer peptide (ankyrin peptide, AnkP) containing the cleavage site completely inhibited the FP-2 enzyme activity in vitro and abolished all of the known functions of FP-2. To determine the effect of this peptide on the growth and development of P. falciparum, the peptide was delivered into intact parasite-infected red blood cells (RBCs) via the Antennapedia homeoprotein internalization domain. Growth and maturation of trophozoites and schizonts was markedly inhibited in the presence of the fused AnkP peptide. <10% of new ring-stage parasites were detected compared with the control sample. Together, our results identify a specific peptide derived from the spectrin-binding domain of ankyrin that blocks late-stage malaria parasite development in RBCs. Confocal microscopy with FP-2-specific antibodies demonstrated the proximity of the enzyme in apposition with the RBC membrane, further corroborating the proposed function of FP-2 in the cleavage of RBC skeletal proteins.  相似文献   
76.
Membrane-associated guanylate kinase homologues (MAGUKs) are generally found under the plasma membrane of cell-cell contact sites and function as scaffolding proteins by linking cytoskeletal and signaling molecules to transmembrane receptors. The correct targeting of MAGUKs is essential for their receptor-clustering function; however, the molecular mechanism of their intracellular transport is unknown. Here, we show that the guanylate kinase-like domain of human discs large protein binds directly within the amino acids 607-831 of the stalk domain of GAKIN, a kinesin-like protein of broad distribution. The primary structure of the binding segment, termed MAGUK binding stalk domain, is conserved in Drosophila kinesin-73 and some other motor and non-motor proteins. This stalk segment is not found in GKAP, a synaptic protein that interacts with the guanylate kinase-like domain, and unlike GKAP, the binding of GAKIN is not regulated by the intramolecular interactions within the discs large protein. The recombinant motor domain of GAKIN is an active microtubule-stimulated ATPase with k(cat) = 45 s(-1), K(0.5 (MT)) = 0.1 microm. Overexpression of green fluorescent protein-fused GAKIN in Madin-Darby canine kidney epithelial cells induced long projections with both GAKIN and endogenous discs large accumulating at the tip of these projections. Importantly, the accumulation of endogenous discs large was eliminated when a mutant GAKIN lacking its motor domain was overexpressed under similar conditions. Taken together, our results indicate that discs large is a cargo molecule of GAKIN and suggest a mechanism for intracellular trafficking of MAGUK-laden vesicles to specialized membrane sites in mammalian cells.  相似文献   
77.
Oxidative stress has been shown to be associated with apoptosis (programmed cell death) in a number of cell systems. We earlier reported in vitro cultured Spodoptera frugiperda (Sf9) cells as a model system to study oxidative stress induced apoptosis (J Biosciences 24 (1999) 13) and the inhibition of UV-induced apoptosis by the baculovirus antiapoptotic p35 protein that acts as a sink to sequester reactive oxygen species (Proc Natl Acad Sci USA 96 (1999) 4838). We now show that UV-induced apoptosis in Sf9 cells, is preceded by the release of mitochondrial cytochrome c into the cytosol and consequent activation of Sf-caspase-1. The inhibitory effect of different antioxidants including scavengers of oxygen radicals such as butylated hydroxyanisole (BHA), alpha tocopherol acetate, benzoate and reduced-glutathione (GSH) on ultra violet B (UVB)-induced apoptosis in cultured Sf9 cells was assessed. Both, cytochrome c release as well as Sf-caspase-1 activation was inhibited by pre-treatment with antioxidants such as BHA and alpha tocopherol acetate, suggesting that these antioxidants inhibit apoptosis by acting quite upstream in the apoptosis cascade at the mitochondrial level, as well as downstream at the caspase level.  相似文献   
78.
Activation by Ca2+, Mg2+, Zn2+, or Mn2+ of adenosine triphosphatases in a microsomal fraction from wheat roots depends upon the growth temperature when the plants are grown under low salt conditions, but not when the plants get a full-strength culture medium. At low ionic strength, cultivation at 25°C gives only half as high activation as cultivation at 18°C or at high ionic strength at both temperatures. Corresponding data for activation of ATPases from oats also show that low ionic strength during growth gives the highest temperature dependence. Low temperature together with low salt conditions during growth gives the highest ATPase activity after stimulation with divalent cations. High growth temperature and full-strength medium decrease the ATPase activity. Activation energies (Ea) were calculated for the two temperature intervals 35–20°C and 20–5°C. The dominating ATPase stimulation (Ca2+ in wheat, Mg2+ in oats) is characterized by high specific activity combined with a low Ea value. The differences in ATPase activity between oats and wheat can be correlated with different cultivation requirements known from agriculture.  相似文献   
79.
80.
cNR, cytosolic nitrate reductase
PM-NR, plasma membrane-bound nitrate reductase

Activities of plasma membrane-bound nitrate reductase (PM-NR) and cytosolic nitrate reductase (cNR) in tobacco (Nicotiana tabacum L. cv. Samsun) are regulated differently, depending upon the nitrate supply to the culture medium (in sand culture). The cNR activity of roots was higher at low nitrate concentrations with the maximum at 5 mM nitrate supply and declined to low values beyond 5 mM . In contrast, the PM-NR activity of roots increased with higher nitrate concentrations with the maximum at 25 mM nitrate and clearly decreased only at 40 mM . This high PM-NR activity correlated with a low growth rate and might be one of the responses to excess nitrate. Internal nitrate and total nitrogen content of the tissues, however, showed a relative minimum in shoots and in roots of between 15 and 25 mM external nitrate. With declining PM-NR activities beyond 25 mM external nitrate, the nitrate content in the tissue increased indicating an inverse relationship between tissue nitrate content and root PM-NR activity. In leaves both NR activities (cNR and PM-NR) correlated with the internal nitrate content, but with a different response at low nitrate.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号